JP2023542124A5 - - Google Patents

Info

Publication number
JP2023542124A5
JP2023542124A5 JP2023517243A JP2023517243A JP2023542124A5 JP 2023542124 A5 JP2023542124 A5 JP 2023542124A5 JP 2023517243 A JP2023517243 A JP 2023517243A JP 2023517243 A JP2023517243 A JP 2023517243A JP 2023542124 A5 JP2023542124 A5 JP 2023542124A5
Authority
JP
Japan
Prior art keywords
gprc5d
bispecific antibody
seq
subject
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023517243A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023542124A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/075523 external-priority patent/WO2022058445A1/en
Publication of JP2023542124A publication Critical patent/JP2023542124A/ja
Publication of JP2023542124A5 publication Critical patent/JP2023542124A5/ja
Pending legal-status Critical Current

Links

JP2023517243A 2020-09-16 2021-09-16 多発性骨髄腫を治療するための方法 Pending JP2023542124A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063079294P 2020-09-16 2020-09-16
US63/079,294 2020-09-16
US202063116549P 2020-11-20 2020-11-20
US63/116,549 2020-11-20
US202163187888P 2021-05-12 2021-05-12
US63/187,888 2021-05-12
PCT/EP2021/075523 WO2022058445A1 (en) 2020-09-16 2021-09-16 Methods for treating multiple myeloma

Publications (2)

Publication Number Publication Date
JP2023542124A JP2023542124A (ja) 2023-10-05
JP2023542124A5 true JP2023542124A5 (https=) 2024-09-25

Family

ID=77924410

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023517243A Pending JP2023542124A (ja) 2020-09-16 2021-09-16 多発性骨髄腫を治療するための方法

Country Status (11)

Country Link
US (1) US20220177584A1 (https=)
EP (1) EP4213945A1 (https=)
JP (1) JP2023542124A (https=)
KR (1) KR20230069959A (https=)
CN (1) CN116322769A (https=)
AU (1) AU2021346129A1 (https=)
BR (1) BR112023004830A2 (https=)
CA (1) CA3194796A1 (https=)
IL (1) IL301361A (https=)
MX (1) MX2023003086A (https=)
WO (1) WO2022058445A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI781108B (zh) 2016-07-20 2022-10-21 比利時商健生藥品公司 抗gprc5d抗體、結合gprc5d與cd3之雙特異性抗原結合分子及其用途
US20260078195A1 (en) 2022-09-09 2026-03-19 Beijing Mabworks Biotech Co., Ltd Multi-specific antibody binding to bcma, gprc5d and cd3, and use thereof
CN117924485A (zh) * 2022-10-25 2024-04-26 上海祥耀生物科技有限责任公司 一种抗gprc5d的多特异性抗体
CN120916780A (zh) 2023-02-28 2025-11-07 詹森生物科技公司 包含双特异性gprc5d/cd3抗体的组合物
AU2024257950A1 (en) * 2023-04-19 2025-12-04 Janssen Biotech, Inc. Methods for treating multiple myeloma
WO2024246856A1 (en) 2023-06-01 2024-12-05 Janssen Biotech, Inc. Methods for treating multiple myeloma
WO2025094085A1 (en) 2023-10-31 2025-05-08 Janssen Biotech, Inc. Combination regimens for treating multiple myeloma

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0281604B1 (en) 1986-09-02 1993-03-31 Enzon Labs Inc. Single polypeptide chain binding molecules
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ES2156149T3 (es) 1992-12-04 2001-06-16 Medical Res Council Proteinas de union multivalente y multiespecificas, su fabricacion y su uso.
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
AU2008343589A1 (en) 2007-12-19 2009-07-09 Centocor Ortho Biotech Inc. Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods
TWI781108B (zh) * 2016-07-20 2022-10-21 比利時商健生藥品公司 抗gprc5d抗體、結合gprc5d與cd3之雙特異性抗原結合分子及其用途
KR20200041834A (ko) * 2017-06-01 2020-04-22 젠코어 인코포레이티드 Cd123 및 cd3에 결합하는 이중특이성 항체
UA130542C2 (uk) * 2018-05-16 2026-03-18 Янссен Байотек, Інк. Антитіло до cd38 та терапевтичний засіб, який перенаправляє т-клітини, для лікування множинної мієломи у суб'єкта
CA3248329A1 (en) * 2019-07-31 2025-11-29 F. Hoffmann-La Roche Ag Antibodies binding to gprc5d

Similar Documents

Publication Publication Date Title
JP2023542124A5 (https=)
JP2021526136A5 (https=)
JP2024540054A5 (https=)
JP2018520101A5 (https=)
IL278667B1 (en) Methods of treating cancers and enhancing efficacy of t cell redirecting therapeutics
JP2017528462A5 (https=)
TWI890481B (zh) 雙特異性抗體
JP2021519295A5 (https=)
JP2015500822A5 (https=)
FI3886875T3 (fi) Adoptiivista soluterapiaa käyttäviä hoitomenetelmiä
CA2984464C (en) Treatment for multiple myeloma (mm)
WO2019186273A4 (en) Subcutaneous dosing of anti-cd38 antibodies
JP2011507932A5 (https=)
JP2023505218A5 (https=)
JP2021528423A5 (https=)
HRP20191115T1 (hr) Anti-cd38 u kombinaciji s kortikosteroidima zajedno s jednim ne-kortikosteroidnim kemoterapeutikom za liječenje tumora
JP2017507953A5 (https=)
EP2192921A1 (de) Intraoperative trifunktionale antikörper-applikation zur prophylaxe intraperitonealer tumorzelldissemination
JP2021512107A5 (https=)
JP2021528438A5 (https=)
JP2023542291A5 (https=)
RU2020112490A (ru) Антитела из тяжелых цепей, связывающиеся с эктоферментами
JP2024534602A5 (https=)
JP2024516698A5 (https=)
WO2022182483A1 (en) Methods for local and systemic treatment of cancers, tumors and tumor cells